ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0314

Microvascular Differences Between Acute and Chronic Cutaneous Graft versus Host Disease

Sehreen Mumtaz1, Florentina Berianu2, Benjamin Wang3, Breanna Cane4 and Olayemi Sokumbi4, 1Mayo Clinic, Florida, Jacksonville, FL, 2mayo clinic, Ponte Vedra Beach, FL, 3Mayo Clinic, Jacksonville, FL, 4Mayo Clinic Florida, Jacksonville, FL

Meeting: ACR Convergence 2024

Keywords: Cutaneous, Miscellaneous Rheumatic and Inflammatory Diseases

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Saturday, November 16, 2024

Title: Miscellaneous Rheumatic & Inflammatory Diseases Poster I

Session Type: Poster Session A

Session Time: 10:30AM-12:30PM

Background/Purpose: Cutaneous involvement in systemic sclerosis (SSc) and chronic sclerodermoid graft versus host disease (GVHD) is visibly indistinguishable and while characteristic nailfold videocapillaroscopy (NVC) patterns are used for prognosticating SSc, utility of NVC for cutaneous GVHD has not been explored. Literature describing NVC in patients with cutaneous graft versus host disease (GVHD) appears to present conflicting data ranging from minor insignificant NVC findings to severe capillary loss, enlarged capillaries with neovascularization and abundant microhemorrhages mimicking capillary leak syndrome. Further study of NVC in GVHD patients is required to investigate changes in capillary architecture during transplant rejection and to identify any microvascular level differences between acute and chronic GVHD.

Methods: Patients with GVHD were recruited from the Mayo Clinic Jacksonville Dermatology clinic, FL based on diagnostic pathology reports. 32 records were screened. Participant information included demographics, type of transplant, pathology findings, conditioning, and anti-rejection regimens, acute or chronic GVHD and degree and type of cutaneous involvement. NVC was performed at time of enrollment using the 2nd-5th digits of both hands. Capillary morphology, density, organization, microhemorrhages, and ramifications of each nailbed were recorded. The study was approved by the Mayo Clinic Institutional Review Board.

Results: A total of 8 patients who received allogeneic stem cell transplant and were diagnosed with GVHD, based on pathology and clinical presentation, were enrolled, and underwent NVC. 50% of the patients (4/8) had pathological confirmation of acute GVHD while 50% (4/8) had chronic GVHD confirmed on biopsy. 63% of the patients were female, 75% Caucasian and 13% African American. The mean age was 69 and 66 years for acute and chronic GVHD patients respectively. The mean time to transplant was 4.25 months for acute GVHD and 21 months for chronic GVHD. There were more enlarged capillaries ( >20 microns but < 50 microns in diameter) and ramifications in chronic GVHD than in acute GVHD patients (Table 1). Both acute and chronic GVHD patients had numerous microhemorrhages (Image 1) with similar elevation of NVC score. Both subsets had comparable disorganized architecture (Image 2).

Conclusion: Acute and chronic GVHD both have numerous microhemorrhages while more enlargements and ramifications were observed in chronic GVHD. These morphological microvascular changes noted in acute and chronic GVHD patients indicate diagnostic value of NVC in these unique subsets.

Supporting image 1

Table 1: Comparison of Nailfold Videocapillaroscopy scores between Acute and Chronic Cutaneous Graft Versus Host Disease.

Supporting image 2

Image 1: Marked diffuse and numerous microhemorrhages were visualized (x200 magnification).

Supporting image 3

Image 2: Distinct disorganization of capillary microstructure (x200 magnification) with disruption of normal capillary array.


Disclosures: S. Mumtaz: None; F. Berianu: None; B. Wang: None; B. Cane: None; O. Sokumbi: None.

To cite this abstract in AMA style:

Mumtaz S, Berianu F, Wang B, Cane B, Sokumbi O. Microvascular Differences Between Acute and Chronic Cutaneous Graft versus Host Disease [abstract]. Arthritis Rheumatol. 2024; 76 (suppl 9). https://acrabstracts.org/abstract/microvascular-differences-between-acute-and-chronic-cutaneous-graft-versus-host-disease/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2024

ACR Meeting Abstracts - https://acrabstracts.org/abstract/microvascular-differences-between-acute-and-chronic-cutaneous-graft-versus-host-disease/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology